The field of urologic oncology is experiencing rapid advancements in recent years, fueled by discoveries in diagnosis, treatment, and patient care. Innovative therapeutic modalities such as targeted therapy and immunotherapy are transforming the landscape of urologic cancer treatment. Additionally,